Greenville, SC, United States of America

Dev P Arya

This inventor holds 6 USPTO granted patents. Top assignees: Clemson University, Nubad, LLC, Florida International University. Active years: 2015-2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Dev P Arya. Retrieved from https://idiyas.com/inventor/dev-p-arya

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 83.3

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2015-2019

Loading Chart...
6 patents (USPTO):Explore Patents

Title: Innovations of Dev P Arya in Nucleic Acid Binding Assays

Introduction

Dev P Arya is an accomplished inventor based in Greenville, SC (US). He has made significant contributions to the field of biotechnology, particularly in the development of methods and compositions related to nucleic acid binding assays. With a total of 6 patents to his name, Arya's work has the potential to impact various applications in drug discovery and molecular biology.

Latest Patents

One of Arya's latest patents focuses on small molecule fluorescent probes for established drug targets such as nucleic acids, including DNA and RNA. These innovative nucleic acid probes are designed to bind to multiple DNA and RNA structures, targeting crucial sites for nucleic acid function, such as the major grooves of DNA and RNA. The unique feature of these probes is their ability to undergo a fluorescence change when displaced by other binders, such as small molecule compounds or proteins. This fluorescence change can be detected and analyzed, providing valuable binding information about these other compounds of interest. Additionally, the changes in fluorescence upon binding of the probes to nucleic acids can be utilized to screen nucleic acids of different sequences and conformations. The disclosed nucleic acid probes and methods are particularly advantageous for high-throughput screening of libraries of small molecule compounds, proteins, and nucleic acids.

Another notable patent by Arya involves the selective inhibition of bacterial topoisomerase I. This invention introduces novel bisbenzimidazole compounds and outlines methods for using these compounds as antibacterial agents. This work showcases Arya's commitment to addressing critical challenges in healthcare and antibiotic resistance.

Career Highlights

Throughout his career, Dev P Arya has worked with esteemed institutions such as Clemson University and Nubad, LLC. His experience in these organizations has allowed him to refine his research skills and contribute to groundbreaking innovations in the field of biotechnology.

Collaborations

Arya has collaborated with notable colleagues, including Nihar Ranjan and Frank Anderson Norris. These partnerships have further enriched his research endeavors and expanded the impact of his inventions.

Conclusion

Dev P Arya's innovative work in nucleic acid binding assays and antibacterial agents highlights his significant contributions to biotechnology. His patents reflect a deep understanding of molecular interactions and a commitment to advancing scientific knowledge. Arya's inventions have the potential to pave the way for new therapeutic strategies and enhance

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…